Bucher HC - Search Results

1

Adherence as a predictor of the development of class-specific resistance mutations: the Swiss HIV Cohort Study.

von Wyl V, Klimkait T, Yerly S, Nicca D, Furrer H, Cavassini M, Calmy A, Bernasconi E, Böni J, Aubert V, Günthard HF, Bucher HC, Glass TR; Swiss HIV Cohort Study. von Wyl V, et al. Among authors: bucher hc. PLoS One. 2013 Oct 16;8(10):e77691. doi: 10.1371/journal.pone.0077691. eCollection 2013. PLoS One. 2013. PMID: 24147057 Free PMC article.

2

[Social class and cardiovascular risk factors in Italian-speaking Switzerland: results of the first Swiss population study MONIKA Project 1985-1986].

Bucher H, Barazzoni F, Rickenbach M, Gutzwiller F. Bucher H, et al. Soz Praventivmed. 1993;38(3):172-8. doi: 10.1007/BF01324351. Soz Praventivmed. 1993. PMID: 8372495 German.

3

Infections requiring hospitalization of injection drug users who participated in an injection opiate maintenance program.

Bassetti S, Hoffmann M, Bucher HC, Fluckiger U, Battegay M. Bassetti S, et al. Among authors: bucher hc. Clin Infect Dis. 2002 Mar 1;34(5):711-3. doi: 10.1086/338876. Epub 2002 Jan 22. Clin Infect Dis. 2002. PMID: 11807681

4

Potential benefit and limitations of a broad access to potent antiretroviral therapy in developing countries.

Kaufmann GR, Smith D, Bucher HC, Phanuphak P, Sendi PP, Mbidde EK, Cooper DA, Battegay M. Kaufmann GR, et al. Among authors: bucher hc. Expert Opin Investig Drugs. 2002 Sep;11(9):1303-13. doi: 10.1517/13543784.11.9.1303. Expert Opin Investig Drugs. 2002. PMID: 12225251 Review.

5

Anxiety in health care workers after exposure to potentially HIV-contaminated blood or body fluids.

Meienberg F, Bucher HC, Sponagel L, Zinkernagel C, Gyr N, Battegay M. Meienberg F, et al. Among authors: bucher hc. Swiss Med Wkly. 2002 Jun 15;132(23-24):321-4. doi: 10.4414/smw.2002.09988. Swiss Med Wkly. 2002. PMID: 12362283 Free article.

6

Meta-analysis of randomized controlled trials of simplified versus continued protease inhibitor-based antiretroviral therapy in HIV-1-infected patients.

Bucher HC, Kofler A, Nüesch R, Young J, Battegay M, Opravil M. Bucher HC, et al. AIDS. 2003 Nov 21;17(17):2451-9. doi: 10.1097/00002030-200311210-00007. AIDS. 2003. PMID: 14600516

7

Stable partnership and progression to AIDS or death in HIV infected patients receiving highly active antiretroviral therapy: Swiss HIV cohort study.

Young J, De Geest S, Spirig R, Flepp M, Rickenbach M, Furrer H, Bernasconi E, Hirschel B, Telenti A, Vernazza P, Battegay M, Bucher HC; Swiss HIV Cohort Study Group. Young J, et al. Among authors: bucher hc. BMJ. 2004 Jan 3;328(7430):15. doi: 10.1136/bmj.328.7430.15. BMJ. 2004. PMID: 14703538 Free PMC article.

8

Sexual risk behavior in HIV-infected injection drug users.

Battegay M, Bucher HC, Vernazza P. Battegay M, et al. Among authors: bucher hc. Clin Infect Dis. 2004 Apr 15;38(8):1175-7. doi: 10.1086/383069. Epub 2004 Apr 5. Clin Infect Dis. 2004. PMID: 15095225 No abstract available.

9

Productivity costs and determinants of productivity in HIV-infected patients.

Sendi P, Schellenberg F, Ungsedhapand C, Kaufmann GR, Bucher HC, Weber R, Battegay M; Swiss HIV Cohort Study. Sendi P, et al. Among authors: bucher hc. Clin Ther. 2004 May;26(5):791-800. doi: 10.1016/s0149-2918(04)90080-x. Clin Ther. 2004. PMID: 15220024

10

Protease inhibitor-sparing simplified maintenance therapy: a need for perspective.

Bucher HC, Young J, Battegay M. Bucher HC, et al. J Antimicrob Chemother. 2004 Aug;54(2):303-5. doi: 10.1093/jac/dkh379. Epub 2004 Jul 21. J Antimicrob Chemother. 2004. PMID: 15269200 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

628 results

Search Page

Filters